Session Details
[S42]Current status and issues of drug-induced liver injury
Sat. Mar 29, 2025 10:15 AM - 11:45 AM JST
Sat. Mar 29, 2025 1:15 AM - 2:45 AM UTC
Sat. Mar 29, 2025 1:15 AM - 2:45 AM UTC
Room 16 (MARINE MESSE FUKUOKA Hall B: Conference Room1-2 [2F])
Organizer: Atsushi Kawase (Fac. Pharm., Kindai Univ.)
趣旨説明:川瀬 篤史(近畿大薬)
[S42-1]Association between risk of drug-induced liver injury and reactive metabolites, acyl glucuronides
○Atsushi Kawase1, Hiroaki Shimada1, Fuminori Sakurai1 (1. Fac. Pharm., Kindai Univ.)
[S42-2]Inflammasome activation and idiosyncratic drug-induced liver injury
-Fusion study of basic and real-world data-
○Ryuji Kato1 (1. Osaka Med. Pharm. Univ.)
[S42-3]Recent insights into HLA-dependent idiosyncratic liver injury
○Shigeki Aoki1, Akira Kazaoka1,2, Kousei Ito1 (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Fac. Pharm., Meijo Univ.)
[S42-4]Elucidation of a novel protective function of AADAC against drug-induced liver injury through ferroptosis suppression
○Tatsuki Fukami1,2 (1. Faculty of Pharmaceutical Sciences, Kanazawa University, 2. WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University)